- call +1-201-465-4211
- email sales@marketquest.biz
- Call +1-201-465-4211
- Email: sales@marketquest.biz
The Chronic Urticaria Or Hives Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest study, due to COVID-19 pandemic, the global Chronic Urticaria Or Hives Drug market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Clinic accounting for % of the Chronic Urticaria Or Hives Drug global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While GDC-0853 segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Chronic Urticaria Or Hives Drug include AstraZeneca Plc, Biofrontera AG, ELORAC, Inc., Faes Farma, SA, and Genentech, Inc., etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Chronic Urticaria Or Hives Drug market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
GDC-0853
GSK-2646264
BF-Derm-1
Bilastine
Others
Market segment by Application can be divided into
Clinic
Hospital
Others
The key market players for global Chronic Urticaria Or Hives Drug market are listed below:
AstraZeneca Plc
Biofrontera AG
ELORAC, Inc.
Faes Farma, SA
Genentech, Inc.
GlaxoSmithKline Plc
J Uriach Y Compania, S.A.
Mabtech Limited
Merck & Co., Inc.
Mycenax Biotech Inc.
Novartis AG
Panacea Biotec Limited
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Chronic Urticaria Or Hives Drug product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Chronic Urticaria Or Hives Drug, with price, sales, revenue and global market share of Chronic Urticaria Or Hives Drug from 2019 to 2022.
Chapter 3, the Chronic Urticaria Or Hives Drug competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Chronic Urticaria Or Hives Drug breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Chronic Urticaria Or Hives Drug market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Chronic Urticaria Or Hives Drug.
Chapter 13, 14, and 15, to describe Chronic Urticaria Or Hives Drug sales channel, distributors, customers, research findings and conclusion, appendix and data source.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1.1 Chronic Urticaria Or Hives Drug Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Chronic Urticaria Or Hives Drug Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 GDC-0853
1.2.3 GSK-2646264
1.2.4 BF-Derm-1
1.2.5 Bilastine
1.2.6 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Chronic Urticaria Or Hives Drug Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Clinic
1.3.3 Hospital
1.3.4 Others
1.4 Global Chronic Urticaria Or Hives Drug Market Size & Forecast
1.4.1 Global Chronic Urticaria Or Hives Drug Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Chronic Urticaria Or Hives Drug Sales in Volume (2017-2028)
1.4.3 Global Chronic Urticaria Or Hives Drug Price (2017-2028)
1.5 Global Chronic Urticaria Or Hives Drug Production Capacity Analysis
1.5.1 Global Chronic Urticaria Or Hives Drug Total Production Capacity (2017-2028)
1.5.2 Global Chronic Urticaria Or Hives Drug Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Chronic Urticaria Or Hives Drug Market Drivers
1.6.2 Chronic Urticaria Or Hives Drug Market Restraints
1.6.3 Chronic Urticaria Or Hives Drug Trends Analysis
2 Manufacturers Profiles
2.1 AstraZeneca Plc
2.1.1 AstraZeneca Plc Details
2.1.2 AstraZeneca Plc Major Business
2.1.3 AstraZeneca Plc Chronic Urticaria Or Hives Drug Product and Services
2.1.4 AstraZeneca Plc Chronic Urticaria Or Hives Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Biofrontera AG
2.2.1 Biofrontera AG Details
2.2.2 Biofrontera AG Major Business
2.2.3 Biofrontera AG Chronic Urticaria Or Hives Drug Product and Services
2.2.4 Biofrontera AG Chronic Urticaria Or Hives Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 ELORAC, Inc.
2.3.1 ELORAC, Inc. Details
2.3.2 ELORAC, Inc. Major Business
2.3.3 ELORAC, Inc. Chronic Urticaria Or Hives Drug Product and Services
2.3.4 ELORAC, Inc. Chronic Urticaria Or Hives Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Faes Farma, SA
2.4.1 Faes Farma, SA Details
2.4.2 Faes Farma, SA Major Business
2.4.3 Faes Farma, SA Chronic Urticaria Or Hives Drug Product and Services
2.4.4 Faes Farma, SA Chronic Urticaria Or Hives Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Genentech, Inc.
2.5.1 Genentech, Inc. Details
2.5.2 Genentech, Inc. Major Business
2.5.3 Genentech, Inc. Chronic Urticaria Or Hives Drug Product and Services
2.5.4 Genentech, Inc. Chronic Urticaria Or Hives Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 GlaxoSmithKline Plc
2.6.1 GlaxoSmithKline Plc Details
2.6.2 GlaxoSmithKline Plc Major Business
2.6.3 GlaxoSmithKline Plc Chronic Urticaria Or Hives Drug Product and Services
2.6.4 GlaxoSmithKline Plc Chronic Urticaria Or Hives Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 J Uriach Y Compania, S.A.
2.7.1 J Uriach Y Compania, S.A. Details
2.7.2 J Uriach Y Compania, S.A. Major Business
2.7.3 J Uriach Y Compania, S.A. Chronic Urticaria Or Hives Drug Product and Services
2.7.4 J Uriach Y Compania, S.A. Chronic Urticaria Or Hives Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Mabtech Limited
2.8.1 Mabtech Limited Details
2.8.2 Mabtech Limited Major Business
2.8.3 Mabtech Limited Chronic Urticaria Or Hives Drug Product and Services
2.8.4 Mabtech Limited Chronic Urticaria Or Hives Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Merck & Co., Inc.
2.9.1 Merck & Co., Inc. Details
2.9.2 Merck & Co., Inc. Major Business
2.9.3 Merck & Co., Inc. Chronic Urticaria Or Hives Drug Product and Services
2.9.4 Merck & Co., Inc. Chronic Urticaria Or Hives Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 Mycenax Biotech Inc.
2.10.1 Mycenax Biotech Inc. Details
2.10.2 Mycenax Biotech Inc. Major Business
2.10.3 Mycenax Biotech Inc. Chronic Urticaria Or Hives Drug Product and Services
2.10.4 Mycenax Biotech Inc. Chronic Urticaria Or Hives Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11 Novartis AG
2.11.1 Novartis AG Details
2.11.2 Novartis AG Major Business
2.11.3 Novartis AG Chronic Urticaria Or Hives Drug Product and Services
2.11.4 Novartis AG Chronic Urticaria Or Hives Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12 Panacea Biotec Limited
2.12.1 Panacea Biotec Limited Details
2.12.2 Panacea Biotec Limited Major Business
2.12.3 Panacea Biotec Limited Chronic Urticaria Or Hives Drug Product and Services
2.12.4 Panacea Biotec Limited Chronic Urticaria Or Hives Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Chronic Urticaria Or Hives Drug Breakdown Data by Manufacturer
3.1 Global Chronic Urticaria Or Hives Drug Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Chronic Urticaria Or Hives Drug Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Chronic Urticaria Or Hives Drug
3.4 Market Concentration Rate
3.4.1 Top 3 Chronic Urticaria Or Hives Drug Manufacturer Market Share in 2021
3.4.2 Top 6 Chronic Urticaria Or Hives Drug Manufacturer Market Share in 2021
3.5 Global Chronic Urticaria Or Hives Drug Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Chronic Urticaria Or Hives Drug Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Chronic Urticaria Or Hives Drug Market Size by Region
4.1.1 Global Chronic Urticaria Or Hives Drug Sales in Volume by Region (2017-2028)
4.1.2 Global Chronic Urticaria Or Hives Drug Revenue by Region (2017-2028)
4.2 North America Chronic Urticaria Or Hives Drug Revenue (2017-2028)
4.3 Europe Chronic Urticaria Or Hives Drug Revenue (2017-2028)
4.4 Asia-Pacific Chronic Urticaria Or Hives Drug Revenue (2017-2028)
4.5 South America Chronic Urticaria Or Hives Drug Revenue (2017-2028)
4.6 Middle East and Africa Chronic Urticaria Or Hives Drug Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Chronic Urticaria Or Hives Drug Sales in Volume by Type (2017-2028)
5.2 Global Chronic Urticaria Or Hives Drug Revenue by Type (2017-2028)
5.3 Global Chronic Urticaria Or Hives Drug Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Chronic Urticaria Or Hives Drug Sales in Volume by Application (2017-2028)
6.2 Global Chronic Urticaria Or Hives Drug Revenue by Application (2017-2028)
6.3 Global Chronic Urticaria Or Hives Drug Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Chronic Urticaria Or Hives Drug Sales by Type (2017-2028)
7.2 North America Chronic Urticaria Or Hives Drug Sales by Application (2017-2028)
7.3 North America Chronic Urticaria Or Hives Drug Market Size by Country
7.3.1 North America Chronic Urticaria Or Hives Drug Sales in Volume by Country (2017-2028)
7.3.2 North America Chronic Urticaria Or Hives Drug Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Chronic Urticaria Or Hives Drug Sales by Type (2017-2028)
8.2 Europe Chronic Urticaria Or Hives Drug Sales by Application (2017-2028)
8.3 Europe Chronic Urticaria Or Hives Drug Market Size by Country
8.3.1 Europe Chronic Urticaria Or Hives Drug Sales in Volume by Country (2017-2028)
8.3.2 Europe Chronic Urticaria Or Hives Drug Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Chronic Urticaria Or Hives Drug Sales by Type (2017-2028)
9.2 Asia-Pacific Chronic Urticaria Or Hives Drug Sales by Application (2017-2028)
9.3 Asia-Pacific Chronic Urticaria Or Hives Drug Market Size by Region
9.3.1 Asia-Pacific Chronic Urticaria Or Hives Drug Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Chronic Urticaria Or Hives Drug Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Chronic Urticaria Or Hives Drug Sales by Type (2017-2028)
10.2 South America Chronic Urticaria Or Hives Drug Sales by Application (2017-2028)
10.3 South America Chronic Urticaria Or Hives Drug Market Size by Country
10.3.1 South America Chronic Urticaria Or Hives Drug Sales in Volume by Country (2017-2028)
10.3.2 South America Chronic Urticaria Or Hives Drug Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Chronic Urticaria Or Hives Drug Sales by Type (2017-2028)
11.2 Middle East & Africa Chronic Urticaria Or Hives Drug Sales by Application (2017-2028)
11.3 Middle East & Africa Chronic Urticaria Or Hives Drug Market Size by Country
11.3.1 Middle East & Africa Chronic Urticaria Or Hives Drug Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Chronic Urticaria Or Hives Drug Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Chronic Urticaria Or Hives Drug and Key Manufacturers
12.2 Manufacturing Costs Percentage of Chronic Urticaria Or Hives Drug
12.3 Chronic Urticaria Or Hives Drug Production Process
12.4 Chronic Urticaria Or Hives Drug Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Chronic Urticaria Or Hives Drug Typical Distributors
13.3 Chronic Urticaria Or Hives Drug Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer
List of Tables
Table 1. Global Chronic Urticaria Or Hives Drug Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Chronic Urticaria Or Hives Drug Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. AstraZeneca Plc Basic Information, Manufacturing Base and Competitors
Table 4. AstraZeneca Plc Major Business
Table 5. AstraZeneca Plc Chronic Urticaria Or Hives Drug Product and Services
Table 6. AstraZeneca Plc Chronic Urticaria Or Hives Drug Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Biofrontera AG Basic Information, Manufacturing Base and Competitors
Table 8. Biofrontera AG Major Business
Table 9. Biofrontera AG Chronic Urticaria Or Hives Drug Product and Services
Table 10. Biofrontera AG Chronic Urticaria Or Hives Drug Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. ELORAC, Inc. Basic Information, Manufacturing Base and Competitors
Table 12. ELORAC, Inc. Major Business
Table 13. ELORAC, Inc. Chronic Urticaria Or Hives Drug Product and Services
Table 14. ELORAC, Inc. Chronic Urticaria Or Hives Drug Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Faes Farma, SA Basic Information, Manufacturing Base and Competitors
Table 16. Faes Farma, SA Major Business
Table 17. Faes Farma, SA Chronic Urticaria Or Hives Drug Product and Services
Table 18. Faes Farma, SA Chronic Urticaria Or Hives Drug Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Genentech, Inc. Basic Information, Manufacturing Base and Competitors
Table 20. Genentech, Inc. Major Business
Table 21. Genentech, Inc. Chronic Urticaria Or Hives Drug Product and Services
Table 22. Genentech, Inc. Chronic Urticaria Or Hives Drug Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. GlaxoSmithKline Plc Basic Information, Manufacturing Base and Competitors
Table 24. GlaxoSmithKline Plc Major Business
Table 25. GlaxoSmithKline Plc Chronic Urticaria Or Hives Drug Product and Services
Table 26. GlaxoSmithKline Plc Chronic Urticaria Or Hives Drug Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. J Uriach Y Compania, S.A. Basic Information, Manufacturing Base and Competitors
Table 28. J Uriach Y Compania, S.A. Major Business
Table 29. J Uriach Y Compania, S.A. Chronic Urticaria Or Hives Drug Product and Services
Table 30. J Uriach Y Compania, S.A. Chronic Urticaria Or Hives Drug Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. Mabtech Limited Basic Information, Manufacturing Base and Competitors
Table 32. Mabtech Limited Major Business
Table 33. Mabtech Limited Chronic Urticaria Or Hives Drug Product and Services
Table 34. Mabtech Limited Chronic Urticaria Or Hives Drug Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. Merck & Co., Inc. Basic Information, Manufacturing Base and Competitors
Table 36. Merck & Co., Inc. Major Business
Table 37. Merck & Co., Inc. Chronic Urticaria Or Hives Drug Product and Services
Table 38. Merck & Co., Inc. Chronic Urticaria Or Hives Drug Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 39. Mycenax Biotech Inc. Basic Information, Manufacturing Base and Competitors
Table 40. Mycenax Biotech Inc. Major Business
Table 41. Mycenax Biotech Inc. Chronic Urticaria Or Hives Drug Product and Services
Table 42. Mycenax Biotech Inc. Chronic Urticaria Or Hives Drug Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 43. Novartis AG Basic Information, Manufacturing Base and Competitors
Table 44. Novartis AG Major Business
Table 45. Novartis AG Chronic Urticaria Or Hives Drug Product and Services
Table 46. Novartis AG Chronic Urticaria Or Hives Drug Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 47. Panacea Biotec Limited Basic Information, Manufacturing Base and Competitors
Table 48. Panacea Biotec Limited Major Business
Table 49. Panacea Biotec Limited Chronic Urticaria Or Hives Drug Product and Services
Table 50. Panacea Biotec Limited Chronic Urticaria Or Hives Drug Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 51. Global Chronic Urticaria Or Hives Drug Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Pcs)
Table 52. Global Chronic Urticaria Or Hives Drug Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 53. Market Position of Manufacturers in Chronic Urticaria Or Hives Drug, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 54. Global Chronic Urticaria Or Hives Drug Production Capacity by Company, (K Pcs): 2020 VS 2021
Table 55. Head Office and Chronic Urticaria Or Hives Drug Production Site of Key Manufacturer
Table 56. Chronic Urticaria Or Hives Drug New Entrant and Capacity Expansion Plans
Table 57. Chronic Urticaria Or Hives Drug Mergers & Acquisitions in the Past Five Years
Table 58. Global Chronic Urticaria Or Hives Drug Sales by Region (2017-2022) & (K Pcs)
Table 59. Global Chronic Urticaria Or Hives Drug Sales by Region (2023-2028) & (K Pcs)
Table 60. Global Chronic Urticaria Or Hives Drug Revenue by Region (2017-2022) & (USD Million)
Table 61. Global Chronic Urticaria Or Hives Drug Revenue by Region (2023-2028) & (USD Million)
Table 62. Global Chronic Urticaria Or Hives Drug Sales by Type (2017-2022) & (K Pcs)
Table 63. Global Chronic Urticaria Or Hives Drug Sales by Type (2023-2028) & (K Pcs)
Table 64. Global Chronic Urticaria Or Hives Drug Revenue by Type (2017-2022) & (USD Million)
Table 65. Global Chronic Urticaria Or Hives Drug Revenue by Type (2023-2028) & (USD Million)
Table 66. Global Chronic Urticaria Or Hives Drug Price by Type (2017-2022) & (USD/Pcs)
Table 67. Global Chronic Urticaria Or Hives Drug Price by Type (2023-2028) & (USD/Pcs)
Table 68. Global Chronic Urticaria Or Hives Drug Sales by Application (2017-2022) & (K Pcs)
Table 69. Global Chronic Urticaria Or Hives Drug Sales by Application (2023-2028) & (K Pcs)
Table 70. Global Chronic Urticaria Or Hives Drug Revenue by Application (2017-2022) & (USD Million)
Table 71. Global Chronic Urticaria Or Hives Drug Revenue by Application (2023-2028) & (USD Million)
Table 72. Global Chronic Urticaria Or Hives Drug Price by Application (2017-2022) & (USD/Pcs)
Table 73. Global Chronic Urticaria Or Hives Drug Price by Application (2023-2028) & (USD/Pcs)
Table 74. North America Chronic Urticaria Or Hives Drug Sales by Country (2017-2022) & (K Pcs)
Table 75. North America Chronic Urticaria Or Hives Drug Sales by Country (2023-2028) & (K Pcs)
Table 76. North America Chronic Urticaria Or Hives Drug Revenue by Country (2017-2022) & (USD Million)
Table 77. North America Chronic Urticaria Or Hives Drug Revenue by Country (2023-2028) & (USD Million)
Table 78. North America Chronic Urticaria Or Hives Drug Sales by Type (2017-2022) & (K Pcs)
Table 79. North America Chronic Urticaria Or Hives Drug Sales by Type (2023-2028) & (K Pcs)
Table 80. North America Chronic Urticaria Or Hives Drug Sales by Application (2017-2022) & (K Pcs)
Table 81. North America Chronic Urticaria Or Hives Drug Sales by Application (2023-2028) & (K Pcs)
Table 82. Europe Chronic Urticaria Or Hives Drug Sales by Country (2017-2022) & (K Pcs)
Table 83. Europe Chronic Urticaria Or Hives Drug Sales by Country (2023-2028) & (K Pcs)
Table 84. Europe Chronic Urticaria Or Hives Drug Revenue by Country (2017-2022) & (USD Million)
Table 85. Europe Chronic Urticaria Or Hives Drug Revenue by Country (2023-2028) & (USD Million)
Table 86. Europe Chronic Urticaria Or Hives Drug Sales by Type (2017-2022) & (K Pcs)
Table 87. Europe Chronic Urticaria Or Hives Drug Sales by Type (2023-2028) & (K Pcs)
Table 88. Europe Chronic Urticaria Or Hives Drug Sales by Application (2017-2022) & (K Pcs)
Table 89. Europe Chronic Urticaria Or Hives Drug Sales by Application (2023-2028) & (K Pcs)
Table 90. Asia-Pacific Chronic Urticaria Or Hives Drug Sales by Region (2017-2022) & (K Pcs)
Table 91. Asia-Pacific Chronic Urticaria Or Hives Drug Sales by Region (2023-2028) & (K Pcs)
Table 92. Asia-Pacific Chronic Urticaria Or Hives Drug Revenue by Region (2017-2022) & (USD Million)
Table 93. Asia-Pacific Chronic Urticaria Or Hives Drug Revenue by Region (2023-2028) & (USD Million)
Table 94. Asia-Pacific Chronic Urticaria Or Hives Drug Sales by Type (2017-2022) & (K Pcs)
Table 95. Asia-Pacific Chronic Urticaria Or Hives Drug Sales by Type (2023-2028) & (K Pcs)
Table 96. Asia-Pacific Chronic Urticaria Or Hives Drug Sales by Application (2017-2022) & (K Pcs)
Table 97. Asia-Pacific Chronic Urticaria Or Hives Drug Sales by Application (2023-2028) & (K Pcs)
Table 98. South America Chronic Urticaria Or Hives Drug Sales by Country (2017-2022) & (K Pcs)
Table 99. South America Chronic Urticaria Or Hives Drug Sales by Country (2023-2028) & (K Pcs)
Table 100. South America Chronic Urticaria Or Hives Drug Revenue by Country (2017-2022) & (USD Million)
Table 101. South America Chronic Urticaria Or Hives Drug Revenue by Country (2023-2028) & (USD Million)
Table 102. South America Chronic Urticaria Or Hives Drug Sales by Type (2017-2022) & (K Pcs)
Table 103. South America Chronic Urticaria Or Hives Drug Sales by Type (2023-2028) & (K Pcs)
Table 104. South America Chronic Urticaria Or Hives Drug Sales by Application (2017-2022) & (K Pcs)
Table 105. South America Chronic Urticaria Or Hives Drug Sales by Application (2023-2028) & (K Pcs)
Table 106. Middle East & Africa Chronic Urticaria Or Hives Drug Sales by Region (2017-2022) & (K Pcs)
Table 107. Middle East & Africa Chronic Urticaria Or Hives Drug Sales by Region (2023-2028) & (K Pcs)
Table 108. Middle East & Africa Chronic Urticaria Or Hives Drug Revenue by Region (2017-2022) & (USD Million)
Table 109. Middle East & Africa Chronic Urticaria Or Hives Drug Revenue by Region (2023-2028) & (USD Million)
Table 110. Middle East & Africa Chronic Urticaria Or Hives Drug Sales by Type (2017-2022) & (K Pcs)
Table 111. Middle East & Africa Chronic Urticaria Or Hives Drug Sales by Type (2023-2028) & (K Pcs)
Table 112. Middle East & Africa Chronic Urticaria Or Hives Drug Sales by Application (2017-2022) & (K Pcs)
Table 113. Middle East & Africa Chronic Urticaria Or Hives Drug Sales by Application (2023-2028) & (K Pcs)
Table 114. Chronic Urticaria Or Hives Drug Raw Material
Table 115. Key Manufacturers of Chronic Urticaria Or Hives Drug Raw Materials
Table 116. Direct Channel Pros & Cons
Table 117. Indirect Channel Pros & Cons
Table 118. Chronic Urticaria Or Hives Drug Typical Distributors
Table 119. Chronic Urticaria Or Hives Drug Typical Customers
List of Figures
Figure 1. Chronic Urticaria Or Hives Drug Picture
Figure 2. Global Chronic Urticaria Or Hives Drug Revenue Market Share by Type in 2021
Figure 3. GDC-0853
Figure 4. GSK-2646264
Figure 5. BF-Derm-1
Figure 6. Bilastine
Figure 7. Others
Figure 8. Global Chronic Urticaria Or Hives Drug Revenue Market Share by Application in 2021
Figure 9. Clinic
Figure 10. Hospital
Figure 11. Others
Figure 12. Global Chronic Urticaria Or Hives Drug Revenue, (USD Million) & (K Pcs): 2017 & 2021 & 2028
Figure 13. Global Chronic Urticaria Or Hives Drug Revenue and Forecast (2017-2028) & (USD Million)
Figure 14. Global Chronic Urticaria Or Hives Drug Sales (2017-2028) & (K Pcs)
Figure 15. Global Chronic Urticaria Or Hives Drug Price (2017-2028) & (USD/Pcs)
Figure 16. Global Chronic Urticaria Or Hives Drug Production Capacity (2017-2028) & (K Pcs)
Figure 17. Global Chronic Urticaria Or Hives Drug Production Capacity by Geographic Region: 2022 VS 2028
Figure 18. Chronic Urticaria Or Hives Drug Market Drivers
Figure 19. Chronic Urticaria Or Hives Drug Market Restraints
Figure 20. Chronic Urticaria Or Hives Drug Market Trends
Figure 21. Global Chronic Urticaria Or Hives Drug Sales Market Share by Manufacturer in 2021
Figure 22. Global Chronic Urticaria Or Hives Drug Revenue Market Share by Manufacturer in 2021
Figure 23. Chronic Urticaria Or Hives Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 24. Top 3 Chronic Urticaria Or Hives Drug Manufacturer (Revenue) Market Share in 2021
Figure 25. Top 6 Chronic Urticaria Or Hives Drug Manufacturer (Revenue) Market Share in 2021
Figure 26. Global Chronic Urticaria Or Hives Drug Sales Market Share by Region (2017-2028)
Figure 27. Global Chronic Urticaria Or Hives Drug Revenue Market Share by Region (2017-2028)
Figure 28. North America Chronic Urticaria Or Hives Drug Revenue (2017-2028) & (USD Million)
Figure 29. Europe Chronic Urticaria Or Hives Drug Revenue (2017-2028) & (USD Million)
Figure 30. Asia-Pacific Chronic Urticaria Or Hives Drug Revenue (2017-2028) & (USD Million)
Figure 31. South America Chronic Urticaria Or Hives Drug Revenue (2017-2028) & (USD Million)
Figure 32. Middle East & Africa Chronic Urticaria Or Hives Drug Revenue (2017-2028) & (USD Million)
Figure 33. Global Chronic Urticaria Or Hives Drug Sales Market Share by Type (2017-2028)
Figure 34. Global Chronic Urticaria Or Hives Drug Revenue Market Share by Type (2017-2028)
Figure 35. Global Chronic Urticaria Or Hives Drug Price by Type (2017-2028) & (USD/Pcs)
Figure 36. Global Chronic Urticaria Or Hives Drug Sales Market Share by Application (2017-2028)
Figure 37. Global Chronic Urticaria Or Hives Drug Revenue Market Share by Application (2017-2028)
Figure 38. Global Chronic Urticaria Or Hives Drug Price by Application (2017-2028) & (USD/Pcs)
Figure 39. North America Chronic Urticaria Or Hives Drug Sales Market Share by Type (2017-2028)
Figure 40. North America Chronic Urticaria Or Hives Drug Sales Market Share by Application (2017-2028)
Figure 41. North America Chronic Urticaria Or Hives Drug Sales Market Share by Country (2017-2028)
Figure 42. North America Chronic Urticaria Or Hives Drug Revenue Market Share by Country (2017-2028)
Figure 43. United States Chronic Urticaria Or Hives Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 44. Canada Chronic Urticaria Or Hives Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 45. Mexico Chronic Urticaria Or Hives Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 46. Europe Chronic Urticaria Or Hives Drug Sales Market Share by Type (2017-2028)
Figure 47. Europe Chronic Urticaria Or Hives Drug Sales Market Share by Application (2017-2028)
Figure 48. Europe Chronic Urticaria Or Hives Drug Sales Market Share by Country (2017-2028)
Figure 49. Europe Chronic Urticaria Or Hives Drug Revenue Market Share by Country (2017-2028)
Figure 50. Germany Chronic Urticaria Or Hives Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. France Chronic Urticaria Or Hives Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. United Kingdom Chronic Urticaria Or Hives Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. Russia Chronic Urticaria Or Hives Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 54. Italy Chronic Urticaria Or Hives Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 55. Asia-Pacific Chronic Urticaria Or Hives Drug Sales Market Share by Region (2017-2028)
Figure 56. Asia-Pacific Chronic Urticaria Or Hives Drug Sales Market Share by Application (2017-2028)
Figure 57. Asia-Pacific Chronic Urticaria Or Hives Drug Sales Market Share by Region (2017-2028)
Figure 58. Asia-Pacific Chronic Urticaria Or Hives Drug Revenue Market Share by Region (2017-2028)
Figure 59. China Chronic Urticaria Or Hives Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Japan Chronic Urticaria Or Hives Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Korea Chronic Urticaria Or Hives Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. India Chronic Urticaria Or Hives Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. Southeast Asia Chronic Urticaria Or Hives Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. Australia Chronic Urticaria Or Hives Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 65. South America Chronic Urticaria Or Hives Drug Sales Market Share by Type (2017-2028)
Figure 66. South America Chronic Urticaria Or Hives Drug Sales Market Share by Application (2017-2028)
Figure 67. South America Chronic Urticaria Or Hives Drug Sales Market Share by Country (2017-2028)
Figure 68. South America Chronic Urticaria Or Hives Drug Revenue Market Share by Country (2017-2028)
Figure 69. Brazil Chronic Urticaria Or Hives Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 70. Argentina Chronic Urticaria Or Hives Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 71. Middle East & Africa Chronic Urticaria Or Hives Drug Sales Market Share by Type (2017-2028)
Figure 72. Middle East & Africa Chronic Urticaria Or Hives Drug Sales Market Share by Application (2017-2028)
Figure 73. Middle East & Africa Chronic Urticaria Or Hives Drug Sales Market Share by Region (2017-2028)
Figure 74. Middle East & Africa Chronic Urticaria Or Hives Drug Revenue Market Share by Region (2017-2028)
Figure 75. Turkey Chronic Urticaria Or Hives Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. Egypt Chronic Urticaria Or Hives Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. Saudi Arabia Chronic Urticaria Or Hives Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 78. South Africa Chronic Urticaria Or Hives Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 79. Manufacturing Cost Structure Analysis of Chronic Urticaria Or Hives Drug in 2021
Figure 80. Manufacturing Process Analysis of Chronic Urticaria Or Hives Drug
Figure 81. Chronic Urticaria Or Hives Drug Industrial Chain
Figure 82. Sales Channel: Direct Channel vs Indirect Channel
Figure 83. Methodology
Figure 84. Research Process and Data Source
Please feel free to write an email to us or to use our electronic ticketing system.
